1. Cancer biomarkers;Henry;Mol Oncol,2012
2. FDA, (2013). Paving the way for personalised medicine: FDA’s role in a new era of medical product development.
3. Policy issues for the development and use of biomarkers in health;OECD,2011
4. The case for personalised medicine;PMC,2014
5. The economics of cancer care in the UK;Bosanquet;Lancet Oncol,2004